Erin Brown Jones advises clients on enforcement, investigations, proactive compliance, and transactional, matters across a range of regulatory regimes, with a focus on DOJ and SEC enforcement, anti-corruption compliance, cross boarder transactional work, and workplace misconduct and anti-discrimination matters. She serves as Co-Deputy Office Managing Partner of the Washington, D.C. office.

 

Erin represents clients in both domestic and cross-border investigations and has experience with government agencies, navigating negotiated settlements and related reporting requirements, engaging with cross-border teams, local counsel, forensic accountants and experts, and interfacing with external auditors, Boards, and other stakeholders. Erin has investigative experience with the Consumer Financial Protection Bureau (CFPB), Drug Enforcement Administration (DEA), and other regulatory agencies, as well as working with clients facing Congressional investigations.

Erin's experience includes investigations and proactive compliance advising around the world, including in -country field work and virtual work in at least dozens of countries across Asia, Europe, the Middle East, and the Americas. Complementing her government-facing work, Erin conducts internal investigations for clients across a range of compliance areas, including highly sensitive allegations of harassment, discrimination, hostile workplace, and retaliation; potential violations of company policies; and concerns regarding fraud, theft, and insider trading.  

In addition to her investigations practice, Erin also works closely with clients across industries – including the manufacturing, technology, life sciences , aerospace, healthcare, and oil and gas industries – to review and enhance their internal compliance programs to align with US government expectations and industry leading practices, including drafting policies and procedures, conducting risk assessments, delivering proactive and insightful training, and advising companies with respect to innovative compliance best practices monitoring and analytics. Erin is a thought leader in the ethics and compliance space, and her expertise ranges from anti-corruption/FCPA to anti-discrimination and civil rights to supply chain risk management (including human rights compliance) to SEC recordkeeping requirements (and beyond).

Erin also regularly advises clients in connection with cross-border M&A, financing, and capital markets transactions, including pre- acquisition due diligence and counseling; post-acquisition diligence, risk assessments, and auditing; and integration support.

Prior to her experience at Latham, Erin held summer fellowships with the DOJ's National Security Division and the Department of Defense’s (DOD) Office of Force Transformation, worked for a Member of the U.S. House of Representatives and also served in the AmeriCorps program.

Erin previously was a member of Latham’s Recruiting Committee and Equal Employment Opportunity (EEO) Review Board.

Erin’s recent investigations experience includes:

  • Tysers Insurance Brokers in responding to anti-bribery and anti-money laundering investigations facing both the DOJ and UK Serious Fraud Office 
  • A major US-based, multinational financial institution in its remediation efforts following its multi-agency and international resolutions of FCPA investigations related to the high-profile 1MDB case. 
  • Compass Minerals in reaching a favorable resolution for an SEC investigation focused on certain of the company’s public disclosures and disclosure controls.
  • A major technology company to obtain a declination from DOJ and a reasonable SEC resolution in an investigation of high-profile alleged FCPA violations in India implicating members of senior management
  • A global manufacturing company in conducting a virtual/remote investigation of potential pre-acquisition bribery by a recently acquired subsidiary in India
  • Mylan N.V. in response to investigations by the House Oversight and Government Reform Committee and the Senate Judiciary Committee, among others, regarding the EpiPen Auto-Injector
  • Several multinational life sciences companies in support of internal and government-facing anti-corruption investigations around the world, including field work in Indonesia, Saudi Arabia, Romania, India, China, and Macedonia
  • Led field work investigations including in Jeddah, Saudi Arabia 
  • Major healthcare company in a DOJ and SEC insider trading case, which was resolved without action against the company or company employees
  • A lobbying and PR firm involved in a criminal investigation involving the Foreign Agents Registration Act
  • A US-based financial institution in connection with a CFPB investigation related to consumer banking, which resulted in the matter being closed
  • Multiple companies – including a major retailer and US healthcare facilities – in responding to investigations by the DEA, all of which resulted in reasonable resolutions
  • An international non-profit organization in conducting an internal investigation into employee misappropriation in the Democratic Republic of Congo, ultimately collaborating with US prosecutors regarding the matter
  • An energy company in an SEC investigation related to complex accounting and disclosure matters, resulting in no enforcement action
  • A US-based manufacturer in obtaining declinations from DOJ and the SEC related to alleged FCPA violations in Poland
  • Multiple aerospace and defense companies in conducting internal investigations and submitting voluntary disclosures to the Department of State’s Directorate of Defense Trade Controls, all of which were closed without action

Erin’s transactional and compliance work includes:

  • A multinational manufacturing company in designing and conducting a comprehensive global anti-corruption risk assessment, including leading field work in Eastern Europe, the Middle East, Latin America, and Asia-Pacific
  • A global technology company in building a world-class anti-corruption compliance program in the wake of a major government investigation
  • A global food services company in designing and implementing a risk-based anti-corruption compliance program following an IPO
  • A multinational pharmaceutical company in conducting a global post-acquisition anti-corruption risk assessment, including leading field work and forensic accounting analysis in Eastern Europe
  • Several major companies – including a technology firm, logistics company, and oilfield services company – in providing real-time analysis and advice regarding third party compliance
  • A Middle Eastern transportation company in developing practical compliance guidance regarding industry-specific corruption risks
  • Multiple private equity firms in advising on anti-corruption risks with respect to acquisition and investment decisions
  • A multinational agriculture company in conducting anti-corruption due diligence on several high-risk acquisition targets in Brazil
  • Several non-profit organizations in designing, implementing, and executing risk-based anti-corruption compliance programs
  • Designing and conducting virtual compliance risk assessments, including for companies in the biotechnology, oil and gas, and aerospace industries

Speaking Engagements

Some of Erin’s recent speaking engagements include: 

  • “Aligning your Compliance Program to DOJ’s Data Analytics Expectations,” Compliance Week, 2024
  • “Anti-Bribery and Corruption: Four Scenarios from Four Perspectives,” ABA ILS Annual Conference, 2024
  • “Key Considerations and Best Practices for Ephemeral Messaging & Off Channel Communications,” Association of Corporate Counsel, 2024
  • “Upgrading Compliance Policies Around Ephemeral Messaging and Retention Systems: Companies Share the Latest Best Practices and Lessons Learned for Employee Training and Risk Management,” 17th Forum on the Foreign Corrupt Practices Act, American Conference Institute, Houston, TX, 2024
  • “Ephemeral Messaging Think Tank: Companies and Financial Institutions Share the Latest Best Practices and Lessons Learned,” 14th West Coast Forum on FCPA Enforcement and Compliance, American Conference Institute, San Francisco, CA, 2023
  • “A New Era of Self-Disclosure and Cooperation Credit – and Your Risk Calculus: What Constitutes Immediate Self-Disclosure, and What are the Enhanced Benefits for Full Cooperation?,” International Conference on the Foreign Corrupt Practices Act, American Conference Institute, Washington, D.C., 2023
  • “White Collar & Compliance Academy: From Abstract to Action - Integrating ESG into Corporate Culture and Compliance,” Latham & Watkins, Webcast, 2023
  • “White Collar & Compliance Academy: Psychology - Investigative Interview Tactics and Perspectives,” Latham & Watkins, Webcast, 2023
  • “Data Analytics to Monitor Payments to HCPs, HCOs, Distributors, and Other Third Parties,” 24th Annual Pharmaceutical Compliance Forum (PCF) Pharmaceutical and Medical Device Ethics and Compliance Congress, 2023
  • “Third Party & Supply Chain Due Diligence, Monitoring and Risk Management: A Closed-Door Discussion of Proven Best Practices and Costly Missteps to Avoid, ” Foreign Corrupt Practices Act Conference, American Conference Institute, Washington, D.C., 2021
  • SEC Enforcement, FCPA and Other Regulatory Compliance, SOX 404 Webinar, 2022
  • “Legal & Compliance Challenges in ESG,” Latham & Watkins and Niederer Kraft Frey Panel Discussion, Zurich, 2022
  • Whistleblowers Fireside Chat, AICPA Fraud Prevention Series, 2022
  • “Preparing for a New Congress: Congressional Oversight of the Private Sector,” Latham & Watkins, Webcast, 2022
  • “Monitoring and Testing Panel,” GIR Live, Washington, D.C., 2021
  • Post-Pandemic Fraud and Internal Controls, SOX 404 Webinar, 2021 
  • “Third Party & Supply Chain Management Handbook: A Comprehensive Guide for Risk Management,” Foreign Corrupt Practices Act Conference, American Conference Institute, Washington, D.C., 2021
  • “From Competition to Collaboration: Shifting the Paradigm,“ The Women in Law & Leadership, CenterForce, Webcast, 2021
  • “What do Biden’s 100 Day Enforcement Priorities Mean for Asia?,” Latham & Watkins, Webcast, 2021
  • “Responding Effectively to Congressional Investigations Under the Democratic House Majority,” Latham & Watkins, Webcast, 2019
  • Government Investigations, Association of Corporate Counsel Webcast, 2019

Bar Qualification

  • District of Columbia

Education

  • JD, Notre Dame Law School, 2010
    magna cum laude
  • MA, University of Chicago, 2006
  • BSFS, Georgetown University, 2005
Jones, Erin Brown
July 10, 2023 Recognition

Rising Star: Latham's Erin Brown Jones

White Collar Defense & Investigations partner Erin Brown Jones of Latham & Watkins LLP has worked on headline-making matters and built long-lasting compliance relationships with major corporate clients, earning her a spot among the compliance law practitioners under age 40 honored by Law360 Rising Stars.